High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia.
about
Huntington's disease geneticsCAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroupIncidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic reviewCurrent Status of Huntington's Disease in Korea: A Nationwide Survey and National Registry AnalysisClinical and genetic features of Huntington disease in Sri Lanka.The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis.CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing.Advances in Huntington's disease diagnostics: development of a standard reference material.De novo mutations in ataxin-2 gene and ALS risk.Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypesThe incidence and prevalence of Huntington's disease: a systematic review and meta-analysis.Polyglutamine (PolyQ) diseases: genetics to treatments.Epidemiological Study of Huntington's Disease in the Province of Ferrara, Italy.The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.What do we know about Late Onset Huntington's Disease?Chronic subdural hematomas in Finnish patients with Huntington's disease.Clinical and genetic characteristics in patients with Huntington's disease from China."Grasping the grey": patient understanding and interpretation of an intermediate allele predictive test result for Huntington disease.HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.Transfer of genetic therapy across human populations: molecular targets for increasing patient coverage in repeat expansion diseases.Huntington's disease in Greece: the experience of 14 years.Molecular diagnosis of Huntington disease in Portugal: implications for genetic counselling and clinical practice.Well-being of family caregivers of persons with late-stage Huntington's disease: lessons in stress and coping.High frequency of intermediate alleles on Huntington disease-associated haplotypes in British Columbia's general population.Huntington disease and Huntington disease-like in a case series from Brazil.The Impact of Family History on the Clinical Features of Huntington's Disease.Comparison of mid-age-onset and late-onset Huntington's disease in Finnish patients.Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG).Huntington disease
P2860
Q22305906-99C840EA-EAEB-450B-A0DB-048836EA4635Q24644358-BCD462BB-2BE5-4641-94FF-C06AFE84EC9AQ28079546-F658D880-5574-4B48-92F2-36E1AEBFBC57Q28652090-A96C4E9D-954E-41B4-B3E7-0AF3569599EFQ33642982-34B3A2E8-39B0-470A-8B19-A7CC0F2C7E52Q34406943-578966DA-E8FA-4BA8-BB24-08FC70B4B19BQ34624785-22CFD6CC-B0B2-4D01-9396-4689D2EE1FEBQ35486706-61344694-5573-483C-8F03-A98B644C1CFAQ36528887-C676EC5C-9DE0-4FF6-BED9-C2860687E393Q37075624-A70B5937-6D4B-4964-AFAC-FECA5777FBC5Q37186056-B73E482D-BB16-4DBF-B90E-005E11143F94Q38018281-9527E68F-D3C8-44DB-85AC-A00847B14E6EQ38210865-EB8EDB31-815A-4540-BCEE-B4EC71C867D7Q38627343-626D92A0-F51C-43B8-B068-871A2AE82F7FQ38663086-6605F3D9-DA3E-4811-AD36-9A5B5D43C22BQ38697127-DDF13AC1-5440-4938-AE3D-4CE649BC7F20Q38858200-8A1DEA26-20EF-4D79-855F-626E7288379DQ39533756-E0EF6F59-B29F-414C-90EE-649A3184E89DQ39567223-130BB33D-1425-4B17-BAE1-BF46B35AFC5EQ42722993-3C3DCED2-DDC5-4B00-B46C-583D39D27FE1Q43082851-4EB4F410-DD7A-4388-BC1B-B84BD0853367Q44252850-D57B34BE-3E6E-46B6-8C71-F3690CF38879Q45291385-B692662C-DBAC-46E4-959C-A825D5485D1DQ45293678-EA82692E-78FE-4D81-AD14-221355FCAD13Q45295031-69781588-38E5-4A70-973B-D5AA9716BD46Q45295295-1B4926B1-B552-47DE-B0AD-D50C8717C72CQ47747838-8BB625E7-9878-42F6-9663-918C6AFEEDDAQ50493951-420AD26F-7DC2-468F-B6BD-3C159A9CAB35Q55410804-E1BA67E7-6964-4E80-A6B3-9B1658160832Q56083219-A68AFA34-6439-488B-8909-6E678C785877
P2860
High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
High incidence rate and absent ...... n disease in British Columbia.
@ast
High incidence rate and absent ...... n disease in British Columbia.
@en
High incidence rate and absent ...... n disease in British Columbia.
@nl
type
label
High incidence rate and absent ...... n disease in British Columbia.
@ast
High incidence rate and absent ...... n disease in British Columbia.
@en
High incidence rate and absent ...... n disease in British Columbia.
@nl
prefLabel
High incidence rate and absent ...... n disease in British Columbia.
@ast
High incidence rate and absent ...... n disease in British Columbia.
@en
High incidence rate and absent ...... n disease in British Columbia.
@nl
P2093
P2860
P1433
P1476
High incidence rate and absent ...... n disease in British Columbia.
@en
P2093
Almqvist EW
Elterman DS
MacLeod PM
P2860
P304
P356
10.1034/J.1399-0004.2001.600305.X
P577
2001-09-01T00:00:00Z